CD87% groups

P value

≥20%

<20%

Count

%

Count

%

Group Total

22

100%

32

100%

TLC groups

<100 × 10⁹/L

17

77.3

23

71.8

0.6

≥100 × 10⁹/L

5

22.7

9

28.2

Hb%

<7 gm/dl

7

31.8%

16

50.0%

≥7 gm/dl

15

68.2%

16

50.0%

0.26

Platelets

<100 × 10³/mm³

16

72.7%

27

84.4%

≥100 × 10³/mm³

6

27.3%

5

15.6%

0.32

Gender

Female

11

50%

15

46.9%

Male

11

50%

17

53.1%

0.82

SPLEEN

No

14

63.6%

18

56.3%

Involved

8

36.4%

14

43.8%

0.59

LIVER

No

14

63.6%

20

62.5%

Involved

8

36.4%

12

37.5%

0.53

L.N

No

20

90.9%

31

96.9%

Involved

2

9.1%

1

3.1%

0.56

CNS

No

22

100.0%

29

90.6%

Involved

_

_

3

9.4%

0.26

Cytogentic criteria

Normal

12

63.2%

19

61.3%

Unfavorable

2

10.5%

1

3.2%

0.64

Favourable

5

26.3%

11

35.5%

FAB

M1

2

9.1%

5

15.6%

M2

1

4.5%

13

40.6%

M3

2

9.1%

6

18.8%

M4

12

54.5%

8

25.0%

0.001^*

M5

4

18.2%

M7

1

4.5%

CR

Not achieved

19

86.4%

14

45.2%

0.002^*

achieved

3

13.6%

17

54.8%